SEC Form 4 · accession 0000899243-19-005709
SUNESIS PHARMACEUTICALS INC · SNSS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William P. Quinn
Officer — See Remarks
Period of report
Feb 28, 2019
Accepted (ET)
Mar 4, 2019 · 3:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061027
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 28, 2019 | A | 63,697 | $0.00 | A | 115,697 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents an incentive bonus paid to the reporting person pursuant to the Issuer's 2018 Bonus Plan. In accordance with the terms of the 2018 Bonus Plan, the reporting person received 50% of his bonus payment in a number of shares of the Issuer's common stock calculated as set forth in the 2018 Bonus Plan.
Remarks
CFO, Sr. V.P. Finance, Corp. Dev.